Burjeel Holdings, DoH Collaborate to host the Global Launch of TIF TDT Guidelines at Arab Health
B urjeel Holdings, in collaboration with the Department of Health Abu Dhabi, has unveiled the ‘Guidelines for the Management of Transfusion-Dependent β -Thalassaemia (TDT)’, the prime resource used by practitioners worldwide to care for patients with TDT. Published by the Thalassaemia International Federation (TIF), the launch took place at Arab Health 2025 in the presence of the TIF leadership and Guidelines Editors Prof. Khaled Musallam, Founding Director, Center for Research on Rare Blood Disorders (CR-RBD), Group Chief Research Officer, Burjeel Holdings, and Prof. Ali Taher, Professor of Medicine, Hematology & Oncology and Director – Naef K. Basile Cancer Institute and VP at the American University of Beirut Medical Center Beirut – Lebanon.
The newly launched guidelines will set new standards for the care of Transfusion- Dependent β-Thalassaemia (TDT) patients
Feat Focus Burjeel Holdings 26
Research & Publications
Made with FlippingBook - professional solution for displaying marketing and sales documents online